GRANTS FOR ANTI-TB DRUGS
The Global Drug Facility (GDF) grant service is a mechanism whereby adult and paediatric first-line anti-TB drugs are granted to approved countries and nongovernmental organizations (NGOs) to support DOTS expansion and sustainability of nationwide coverage in countries that don't have sufficient finances for their drug needs and who lack adequate procurement capacity, including a robust quality assurance system.
GDF grants run in three-year cycles and are subject to the satisfactory compliance with GDF terms and conditions of support and to the availability of resources available to National TB Control Programmes. Calls for applications for grants are made in accordance with the availability of funding.
GDF also offers emergency grants of one year to prevent stockouts due to events such as natural disasters and humanitarian crises.
For information on the GDF grant application review process, please follow the links below:
To apply, please see the documents below or email us at gdf@who.int.
Please send the application form to the following address:
Global Drug Facility
Stop TB Partnership Secretariat
c/o World Health Organization
20, avenue Appia
CH-1211 Geneva 27
Switzerland
Fax: +41 22 791 4886/ +41 22 791 4486
Email:
gdf@who.int
|
